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RESEARCH ARTICLE

Organ-distribution of the metabolite 2-aminothiazoline-4carboxylic acid in a rat model following cyanide exposure
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Abstract
The reaction of cyanide (CN−) with cystine to produce 2-aminothiazoline-4-carboxylic acid (ATCA) is one of the
independent detoxification pathways of cyanide in biological systems. In this report, in vivo production of ATCA
and its distributions in plasma and organs were studied after a subcutaneous sublethal dose of 4 mg/kg body
weight potassium cyanide (KCN) administration to rats. At this sublethal dose of KCN, ATCA concentration was not
significantly increased in the plasma samples, however, it was found significantly increased in liver samples. These
results suggested that ATCA might not be a good diagnostic biomarker in plasma for sublethal cyanide exposure;
however, liver could serve as the right organ for the detection of ATCA in post-mortem examinations involving
cyanide exposure in military, firefighting, industrial and forensic settings.
Keywords: Diagnostic biomarker, forensic biomarker, cyanide poisoning, 2-aminothiazoline-4-carboxylic acid (ATCA),
LC-MS/MS

Introduction

by: (1) in vivo measurements of ATCA concentrations
in plasma, and (2) post-mortem measurements of the
distribution of ATCA amongst organs following cyanide
exposure in a rat system.
Cyanide exposure occurs in military, firefighting,
industrial and forensic settings. Although potassium
cyanide (KCN) can be produced from a non-toxic source,
such as cooking potassium ferrocyanide (Musshoff et al.
2011), cyanide exposures most commonly originate from
smoke inhalation or direct exposure to either cyanide salt
or hydrogen cyanide (HCN). In an ambient environment,
cyanide salts usually appear as white crystalline powders,
while HCN is present as colorless (or pale blue) liquid or
as gas with a bitter almond-like odor (Lv et al. 2005). In
the investigation of deaths, a bitter almond odor emanating from the victim, and the presence of pink lividity from
post-mortem examination are two common indicators of
acute cyanide poisoning (Gill et al. 2004). Alkali burns

Human metabolism of cyanide and detection of its biomarkers has been described in detail by Baskin et al.
(1997, 2006). Briefly, thiocyanate (SCN−), 2-aminothiazoline-4-carboxylic acid (ATCA), and cyanide-protein
adducts in biological fluids and tissues are alternative biomarkers for cyanide exposure and poisoning.
Although SCN− is the major cyanide metabolite found in
blood (Baskin et al. 2004), it is also a natural metabolite
of non-cyanide mediated pathways and thus it is not a
specific marker for cyanide poisoning (Ballantyne et al.
1977). On the other hand, ATCA has been identified and
suggested as an alternative chemically stable biomarker
for cyanide exposure (Logue et al. 2010). Unfortunately,
ATCA half-life and distribution of ATCA due to cyanide
exposure have not yet been studied or published. The
purpose of this study was to evaluate the potential use of
ATCA as a diagnostic biomarker for cyanide poisoning
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Organ-distribution of ATCA
of the gastrointestinal tract tract can often be observed
during autopsy in cases where cyanide salts have been
ingested. Since cyanide salts are solid crystalline, their
presence in a crime scene or in the areas near victim’s
nose or mouth can be easily discovered, collected and
preserved for further forensic testing. In cases where
no suspicious substances are observed at the scene of
death, the presence of cyanide in the victim’s body can
be confirmed chemically using a colorimetric test, followed by laboratory analysis using gas chromatography
mass spectrometry (GC–MS). Forensic evidences, such
as stomach contents and whole blood of the victims, are
usually collected and analysed in order to confirm the
cause of death (Laforge et al. 1994).
The toxicological detection of cyanide involves
extraction and measurement of HCN from biological
extracts (Darr et al. 1980; Shiono et al. 1991). Blood or
urine can be collected from the victim for laboratory
analysis (Lundquist et al. 1989; McAuley et al. 1983;
Zamecnik et al. 1987). Due to the relatively short halflife of cyanide (from minutes to hours depending on the
matrix), toxicological detection of cyanide to confirm
cyanide poisoning may only be feasible within the first
few hours following exposure (Calafat & Stanfill 2002;
Moriya & Hashimoto 2001). Moreover, the volatility and
reactivity of cyanide give direct measurements highly
susceptible to errors introduced during the sample collection and separation step (Lindsay et al. 2004). Cyanide
levels in blood samples taken at autopsy the next day
have been reported to decrease by approximately 79%
(Curry 1963). Post-mortem formation of cyanide may
also occur and complicates the interpretation of cyanide
results (McAllister et al. 2008). Therefore, the presence of
cyanide becomes less feasible when the detection window is passed or the victims’ body has been damaged,
such as might be the case when autopsies are delayed
or when tissues have been damaged by fire or advanced
decomposition. The detection of stable biomarkers of
cyanide is a promising approach to extend the time in
which cyanide exposure can be reliably assayed in a
post-mortem examination.

Materials and methods
Chemicals and samples
All solvents used in this study were at least HPLC grade.
Trifluoroacetic acid (TFA) was obtained from EMD
Chemicals (Gibbstown, NJ, USA) and used to prepare
0.5% (v/v) TFA in methanol as the mobile phase. ATCA
was obtained from Chem-Impex International (Wood
Dale, IL, USA). 2-Aminothiazole-4-carboxylic acid (ATZA)
was obtained from Synthonix (Wake Forest, NC, USA).
KCN was purchased from Sigma-Aldrich (St. Louis,
MO, USA). For in vivo study, serial dilutions were used
to produce aqueous KCN solutions of systematically
decreasing concentration. Oasis® MCX (mixed-mode
cation exchange) cartridges were obtained from Waters
Corporation (Milford, MA, USA).
© 2011 Informa UK, Ltd.
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Animals
Male CD rats weighing 250–300 grams with catheters
implanted were purchased from Charles River (Charles
River Breeding Laboratories, Inc., Wilmington, MA,
USA) The experimental animals were housed in temperature and light controlled rooms (22 ± 2°C, 12 h light/
dark cycle). They were furnished with water and Teklad
Rodent Diet (W) 8604 (Teklad HSD, Inc., WI, USA)
ad libitum. All animal procedures were conducted
in accordance with the guidelines in The Guide for
the Care and Use of Laboratory Animals (National
Academic Press, 1996). The research facility was accredited by American Association for the Assessment and
Accreditation of Laboratory Animal Care, International
and this animal study was approved by the Institutional
Animal Care and Use Committee at Sam Houston State
University (SHSU).

In vivo production of ATCA in plasma
Three rats were received 4 mg/kg body weight KCN solution subcutaneously. Before injection, blood was drawn
to establish baseline endogenous ATCA levels at the zero
time point. After exposing the rats by injecting the KCN
solutions subcutaneously, blood samples were taken
through the catheters at the following time intervals: 5,
15, 30, 60 min, and 2, 4, 6, 12, 15, 50.5 h. For each withdrawal of blood, lock solutions were drawn out till blood
appeared in the catheter; 320 μL blood was collected from
each rat; 320 μL of isotonic saline was injected back into
the rat and the catheter was resealed with 100 μL of the
lock solution. Individual samples were deposited into a
15 mL tube (15 mL/tube) that had been pre-washed with
heparin to prevent coagulation. The heparinized blood
samples were than centrifuged at 2000 rpm for 10 min at
+4°C (VWR Model 5810R, VWR International, Dallas, TX
75267) to prepare plasma samples for ATCA analysis.

Organs distribution study
Following the plasma measurements discussed above,
different groups of animals were used in a series of measurements (Table 1) to determine organ-distribution
of ATCA following sublethal cyanide exposure. Organs
(liver, heart, kidneys, spleen, brain, and lungs) of the rats
were collected after subcutaneous injection of KCN at
sublethal dose of 4 mg/kg body weight. KCN was injected
with a 25 G × 1½ needle. Rats were terminated at 30 and
60 min, 4 and 12 h after cyanide exposure and organs
were collected. Organ samples were placed into plastic 3 mL tubes and stored in the freezer until they were
thawed for analysis.

Sample preparations and ATCA measurement
Cation exchange solid-phase extraction (SPE) columns
and individual pre-treatment steps for the extraction
and analysis of ATCA from biological samples have
been reported (Bradham et al. 1965; Lundquist et al.
1995). In our work, ATCA was extracted from biological samples by SPE. Detection and quantification of
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ATCA was accomplished by using a liquid chromatography-tandem mass spectrometer (LC-MS/MS). Sample
preparation and instrumentation details of electrospray
ionization/tandem mass spectrometer (ESI/MS/MS)
for the detection of ATCA can be found in our previous report (Jackson et al. 2010). Briefly, tissue samples
were homogenized with ready-to-use Precellys®
lysing kits on a Precellys-24 tissue homogenizer (Bertin
Technologies, France). ATCA was extracted from
homogenates by SPE, which was performed in a glass
manifold equipped with Teflon needle inserts and evacuated with a Buchi V-700 Vacuum Pump (Mallinckrodt
Baker, Inc., Phillipsburg, NJ, USA). After SPE, Pierce
Reacti-Therm II Heating Module was used to stream air to
dry elution solvent in borosilicate glass disposable culture
tubes (13 × 100 mm). A Shimadzu liquid chromatograph
(LC-20AT, Shimadzu, Columbia, MD, USA) coupled to a
tandem mass spectrometer (API 3200 ESI/MS/MS system,
Applied Biosystems, Foster City, CA, USA) was employed
for the LC-MS/MS separation, detection and quantification of ATCA. A Luna CN column (3 micron, 100 × 2 mm;
Phenomenx; Torrance, CA, USA) was used for the separation. A 5 μL aliquot of sample after SPE was injected to

the LC-MS/MS by an auto-sampler, and eluted isocratically at a 0.5 mL/min flow rate. Electrospray ionization
(ESI) was used at the LC and MS/MS interface. Transition
ions of ATCA (m/z 147+ → 101+) and ATZA (m/z 145+
→ 127+) were monitored under multiple reaction monitoring mode. The conditions of ESI were as follows: Ion
spray voltage: +5500 volts, temperature: 450°C, curtain
gas 50 psi, gas 1: 70 psi, gas 2: 20 psi. The MS/MS parameters were as follows: Collision gas (collision-activated
dissociation): 6 psi, collision cell entrance potential: 14
volts, and the collision cell exit potential: 4 volts.

Results
Plasma ATCA concentration after cyanide exposure
As shown in Figure 1, the endogenous level of ATCA in
these experimental rats was 222 ± 19 (n = 3) ng/mL. The
mean of ATCA level in plasma after KCN exposure within
the experimental period was 203 ± 26 (n = 30) ng/mL.
This result suggests that ATCA concentrations in plasma
samples were not increased when the experimental
animals (rats) were exposed to the sublethal dose of
4 mg/kg body weight of KCN.

Table 1. Organ collection for ATCA measurement.
Organ sampling groups
30 min
60 min
4 mg/kg
Rat #4
Terminate
4 mg/kg
Rat #5
Terminate
4 mg/kg
Rat #6
Terminate
4 mg/kg
Rat #7
Terminate
4 mg/kg
Rat #8
Terminate
4 mg/kg
Rat #9
Terminate
4 mg/kg
Rat #10
4 mg/kg
Rat #11
4 mg/kg
Rat #12
4 mg/kg
Rat #13
4 mg/kg
Rat #14
4 mg/kg
Rat #15
Note: Rats #1–#3 were used for the measurement of endogenous ATCA levels in organs.

4h

12 h

Terminate
Terminate
Terminate
Terminate
Terminate
Terminate

Figure 1. Plasma ATCA concentration after cyanide exposure (4 mg/kg body weight KCN administration (sc) to rats).
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ATCA concentrations in organs after cyanide exposure
As shown in Figure 2, ATCA concentration levels in organs
were all increased after injection of KCN. The increase in
ATCA concentration was most significant in the liver, rising from an endogenous level of 0.85 ± 0.4 (n = 3) µg/g to
a level of 33 ± 7 (n = 3) µg/g at 12 h after exposure.

Discussion
The primary purpose of this toxico-kinetics study, funded
by National Institute of Health (NIH), was to determine
the role of ATCA to serve as a diagnostic biomarker for
detecting cyanide exposure. Based on the results of this
study, ATCA was not proved to be a good diagnostic
biomarker when analysing plasma in the species of rat
after sublethal dose cyanide exposure. Ongoing studies
are focusing on higher, but still sublethal doses of KCN
(8 mg/kg body weight) exposures, and collecting urine as
well as an alternative biological matrix to analyse ATCA
level as a part of the search for diagnostic biomarkers for
cyanide exposure.
When analysing various organs, such as liver, kidney,
heart, spleen, brain and lungs, these results suggest that
ATCA potentially can serve as a forensic biomarker for
post-mortem examination of victims of cyanide exposure. The purpose of forensic toxicological test for cyanide is to provide quantitative analysis of cyanide from
samples collected from a victims’ body. Usually, whole
blood is tested. Natural dietary and pulmonary intake of
cyanide from the environment, such as cyanogenic glycosides in food, vehicle exhaust, cigarette, smoke from
fires, leads to a non-zero cyanide background level in the
body (Noguchi et al. 1988). For example, the burning of
nitrogen-containing polymeric materials can introduce
sufficient HCN to be lethal for those enhaling the smoke
(Ishii et al. 1998). Human endogenous levels of cyanide
are typically less than 40 ng/mL in plasma. Cyanide concentrations greater than 2500 ng/mL are fatal in humans.
Thus, the lethal dose of HCN of human is about 1 mg/kg
body weight. In certain environments such as fires, cyanide can continue to diffuse into a body following death

(Karhunen et al. 1991). When victims are removed from
such cyanide enriched environments, the rapid decomposition of cyanide in biological matrices results in a
systematic decrease in measurable cyanide (McAllister
et al. 2008). Therefore, a complementary metabolic biomarker would be useful for opening a larger window for
post-mortem analysis, and a more accurate assessment
of the causal relationship between cyanide exposure and
cause of death.
In the field of cyanide research, it has been well known
that detoxification of cyanide by cystine produces ATCA
in vivo (Wood & Cooley 1956). The formation mechanism
of stable cyanide-protein adducts, such as the reaction of
cyanide with the C-terminal Cys558 Cys567 disulfide bond
of human serum albumin (Fasco et al. 2011), is similar
to that of ATCA. It has been suggested in an in vivo study
that the reaction of an oxidized disulfide with a sulfur
nucleophile from glutathione could be a plausible origin
for ATCA (Zottola et al. 2009). It is likely that endogenous
levels of ATCA in each organ reflect the availability of
disulfide and the concentration of glutathione in those
organs. Thus, endogenous ATCA levels may give an estimate of each organ’s capacity for cyanide detoxification.
For example, the results showing lower endogenous
ATCA levels in the brain may be consistent with lower
capacity for cyanide detoxification in this organ. This
lower capacity might be partially due to the absence of
rhodanese enzymes in the brain.
The pathway producing ATCA was estimated approximately 20% of cyanide metabolism (Baskin & Brewer
1997). The quantity of ATCA produced has been found
to be directly proportional to the amount of cyanide
metabolized. ATCA is metabolically inert in experimental rats and is stable in urine matrix for months in
the freezer (Logue et al. 2005). Therefore, ATCA seems a
promising candidate as a chemically stable biomarker of
cyanide. Although ATCA production is not significant in
plasma at sublethal doses of cyanide, its concentration in
liver samples was significantly increased. Future studies
will also focus on the determination of ATCA concentrations in human plasma and liver samples, and stability of

Figure 2. TCA concentrations in organs after cyanide exposure (4 mg/kg body weight KCN administration (sc) to rats).
© 2011 Informa UK, Ltd.
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ATCA in the post-mortem matrix as a part of future forensic research on ATCA. These studies will be supported
by the College of Criminal Justice of SHSU, and will be
independent from the present NIH–supported diagnostic biomarker studies. In an investigation of death in a
fire scene, one of the important questions is whether the
victim was alive at the beginning of fire. An interesting
project for future study is to see whether post mortem
HCN diffusion can produce ATCA in liver samples.
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